Efficient and standardized in vitro expansion solution for human NK cells

Author: Senior Product Manager of UA Views：62

Natural killer cells (NK cells), as key effector cells of the innate immune system, possess the ability to recognize and kill tumor cells in an MHC-unrestricted manner, demonstrating significant clinical application potential in the field of adoptive cell immunotherapy (ACT).

Recent Advances
Product Information

Recent Advances

Efficient and Standardized In Vitro Expansion Solution for Human NK Cells

NK Cells: Core Effector Cells in Tumor Immunotherapy

Natural Killer (NK) cells, as key effector cells of the innate immune system, possess the ability to recognize and kill tumor cells in an MHC-unrestricted manner, demonstrating significant clinical potential in adoptive cell immunotherapy (ACT). However, challenges such as low proportion in peripheral blood (approximately 5%~15%), difficulty in in vitro expansion, and functional exhaustion severely limit their large-scale application in CAR-NK, NK cell infusion therapies, and tumor immunology research.

UA BIOSCIENCE, a leader in cellular immunology research tools, presents the Human NK Cell Expansion Cytokine Kit (UA090009), offering researchers and industrial users a systematically validated, standardized, and highly efficient solution for in vitro NK cell culture.

Core Technical Principles

The in vitro expansion of NK cells relies not only on cytokine support but also on effective activation signals. This solution is scientifically designed at three levels:

1. Multi-Factor Synergistic Signaling Network

- IL-2 (200 ng/mL): A classic NK cell growth factor promoting proliferation and survival;

- IL-15 (100 ng/mL): A core cytokine for NK cell development and homeostasis, enhancing cytotoxic activity;

- IL-18 (100 ng/mL): Synergizes with IL-12/IL-15 signaling to promote IFN-γ secretion, strengthening NK cell effector function;

- Anti-CD56 Antibody (2.5 μg/mL): Provides activation signals through CD56 cross-linking, inducing NK cells into an active proliferative state.

The combination of these four factors forms a complete "proliferation-survival-activation" signaling loop, significantly improving expansion efficiency and functional activity.

2. Standardized Temporal Culture Protocol

This kit provides a detailed, standardized operational protocol from Day 0 to Day 11 (extendable to Day 14+), covering cell density control, medium replenishment strategies, and assessment checkpoints:

Culture Stage	Key Operational Points
Day 0	PBMCs are seeded at 1×10⁶ cells/mL in 24-well plates after magnetic bead sorting, with full cytokine supplementation to initiate culture
Day 3	First passage, adjusting cell density to 5×10⁵ cells/mL, transferring to 6-well plates, and supplementing fresh medium and cytokines
Day 5 / Day 7	Medium change or centrifugation/resuspension based on cell status (viability, debris rate) to maintain optimal conditions
Day 9	Transfer to T25 flasks for larger-scale expansion, using half-medium change to minimize operational damage
Day 11+	Harvest cells for phenotype identification and functional assays; extendable to Day 14+ for larger-scale needs

3. Compatibility and Flexibility

The recommended medium formulation (KBM581 + 5% human AB serum + 1% dual antibiotics + 55 μM β-mercaptoethanol) is optimized and validated, while allowing flexibility for adjustments based on experimental needs.

Validation Data:

Core Product Advantages

✅ Ready-to-use kit, simplifying experimental design: Pre-optimized cytokine ratios eliminate the need for tedious single-factor screening, significantly shortening preparation time.

✅ High expansion efficiency for preclinical research: Validated across multiple donors, this protocol ensures sufficient NK cell yield for downstream experiments and animal models.

✅ Standardized workflow: Detailed step-by-step protocols with quality control checkpoints.

✅ High cell viability: Precise medium change and passage strategies with sustained cytokine supply minimize apoptosis and functional exhaustion, maintaining high cytotoxic activity.

Typical Applications

1. Fundamental tumor immunology research: NK cell receptor-ligand interactions, signaling mechanisms;

2. Adoptive cell therapy development: Preclinical preparation of CAR-NK and universal NK cell products;

3. Drug screening and evaluation: Antibody-dependent cell-mediated cytotoxicity (ADCC) assays;

4. Immunomodulation studies: NK cell functional regulation in infections and autoimmune diseases.

Conclusion

In the rapidly advancing field of NK cell immunotherapy, the UA090009 Human NK Cell Expansion Cytokine Kit offers researchers a one-stop solution from "NK cell acquisition" to "high-efficiency expansion," featuring precise scientific formulations, stringent quality control, and standardized protocols.

This article is reviewed and published by the technical expert team of UA

Disclaimer: This article partially utilizes artificial intelligence assistance in its creation. If any content involves copyright or intellectual property issues, please let us know and we promise to verify and remove it as soon as possible.

Purchase recombinant protein, choose Nanjing UA-Bio

UA protein focuses on providing various protein reagents, raw materials, and services required for drug research and development, cell therapy, gene therapy, and basic scientific research, including drug target proteins, immune checkpoint proteins, cytokines, tool enzymes, customized protein expression, and full-length transmembrane protein development. Youai is committed to providing customers with high-quality products and professional services, and building a High-tech Biological Enterprise with International Competitiveness.

Buy antibodiesFind UA www.ua-bio.com | 15 years of protein development experience

Nanjing UA Biotechnology Co., Ltd. Email：order@ua-bio.com Phone：+86-25-56221161

more products

Product Information

The Last The Next